ClearLight Dx Raises $2.8M

May 08, 2018

|

NEW YORK (360Dx) – ClearLight Diagnostics said today that it has completed a $2.77 million financing round.

Participants in the financing round included CS Investors, Pivotal Paramount Investment, and Stanford University. The financing will be used to continue development of ClearLight's platform, it said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

ClearLight Dx Raises $2.8M

To read the full story....

Breaking News

FDA Grants Emergency Use Authorization for George Washington University Coronavirus PCR Test

Adaptive Biotechnologies Q2 Revenues Fall 5 Percent, Beat Analyst Estimates

Castle Biosciences Q2 Revenues Up 18 Percent

HTG Molecular Diagnostics, Qiagen Ink CDx Commercialization, Distribution Agreement

Helix Gets FDA Emergency Use Authorization for NGS-Based COVID-19 Test

BioMérieux, Beijing Wantai Coronavirus Antibody Tests Get FDA Emergency Use Authorization

What's Popular?

Sysmex America to Distribute Siemens Urine Analyzer in North America

BioMérieux, Beijing Wantai Coronavirus Antibody Tests Get FDA Emergency Use Authorization

Thermo Fisher Teams With Academic Labs on COVID-19 Antibody Test for Transplant Market

Luminex Responds to FDA Warning Letter While Ramping SARS-CoV-2 Test Manufacturing

Meridian Bioscience Fiscal Q3 Revenues Soar 75 Percent on COVID-19-Related Life Sciences Growth

Sponsorships